Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir

BACKGROUND: Study C210 was a Phase IIa, exploratory trial to assess the activity of telaprevir on hepatitis C virus (HCV) early viral kinetics in treatment-naïve patients infected with genotype 4 (G4) HCV. METHODS: Patients were randomized to receive peginterferon and ribavirin alone, telaprevir mon...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: De Meyer, Sandra, Ghys, Anne, Dierynck, Inge, Beumont, Maria, Luo, Donghan, Picchio, Gaston
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030523/
https://ncbi.nlm.nih.gov/pubmed/24886541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-11-93
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky